{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:17:00Z","timestamp":1761895020446,"version":"3.44.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1016\/j.annder.2009.12.003","type":"journal-article","created":{"date-parts":[[2010,1,6]],"date-time":"2010-01-06T05:45:47Z","timestamp":1262756747000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["\u00c9v\u00e9nements cutan\u00e9omuqueux au cours des traitements par anti-TNF alpha\u00a0: \u00e9tude observationnelle prospective de 41\u00a0cas"],"prefix":"10.1016","volume":"137","author":[{"given":"N.","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Guis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-C.","family":"Koeppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Roudier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-C.","family":"Grimaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.-J.","family":"Jean-Pastor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Berbis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2009.12.003_bib1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/09546630802441234","article-title":"Induction and exacerbation of psoriasis with TNF-blockade therapy: a review and analysis of 127 cases","volume":"20","author":"Ko","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.annder.2009.12.003_bib2","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/ard.2007.087288","article-title":"Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor \u03b1 therapy: results from the British Society for Rheumatology Biologics Register","volume":"68","author":"Harrison","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2009.12.003_bib3","first-page":"111","article-title":"Imputabilit\u00e9 des effets inattendus ou toxiques des m\u00e9dicaments","volume":"40","author":"B\u00e9gaud","year":"1985","journal-title":"Therapie"},{"key":"10.1016\/j.annder.2009.12.003_bib4","doi-asserted-by":"crossref","first-page":"R666","DOI":"10.1186\/ar1724","article-title":"Dermatological conditions during TNF-\u03b1-blocking therapy in patients with rheumatoid arthritis: a prospective study","volume":"7","author":"Flendrie","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.annder.2009.12.003_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1159\/000069965","article-title":"Adverse skin reactions to anti TNF-alpha monoclonal antibody therapy","volume":"206","author":"Devos","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2009.12.003_bib6","first-page":"188","article-title":"Lichen planus associated with etanercept","volume":"158","author":"Battistella","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2009.12.003_bib7","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.142.2.198","article-title":"Interstitial granulomatous dermatitis associated with the use of tumor necrosis factor \u03b1 inhibitors","volume":"142","author":"Deng","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.12.003_bib8","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0151-9638(07)89187-3","article-title":"Manifestations cutan\u00e9es observ\u00e9es au cours d\u2019un traitement par anti-TNF\u03b1\u00a0: 11\u00a0observations","volume":"134","author":"Lebas","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.12.003_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archderm.143.2.223","article-title":"Psoriasis and pustular dermatitis triggered by TNF-( inhibitors in patients with rheumatologic conditions","volume":"143","author":"De Gannes","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.12.003_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/ard.2005.037424","article-title":"New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor ( antagonists","volume":"65","author":"Kary","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.annder.2009.12.003_bib11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000107622","article-title":"Cutaneous manifestations in inflammatory bowel diseases: eight cases of psoriasis induced by anti-tumor-necrosis-factor antibody therapy","volume":"215","author":"Passarini","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.annder.2009.12.003_bib12","first-page":"2432","article-title":"Primary cutaneous Nocardia otitidiscaviarum infection in a patient with rheumatoid arthritis treated with infliximab","volume":"32","author":"Fabre","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.annder.2009.12.003_bib13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1468-3083.2007.02165.x","article-title":"Two cases of atopic dermatitis-like conditions induced in psoriasis patients treated with infliximab","volume":"21","author":"Vestergaard","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.annder.2009.12.003_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/MD.0b013e3181441a68","article-title":"Autoimmune diseases induced by TNF-targeted therapies, analysis of 233 cases","volume":"86","author":"Ramos-Casals","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.annder.2009.12.003_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(05)67763-X","article-title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","volume":"367","author":"Tyring","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2009.12.003_bib16","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1067\/mjd.2001.117725","article-title":"Rapid onset of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis after starting tumor necrosis factor \u03b1 receptor IgG1-Fc fusion complex therapy","volume":"45","author":"Smith","year":"2001","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl.","key":"10.1016\/j.annder.2009.12.003_bib17","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/j.jaad.2003.11.044","article-title":"Acute development of multiple keratoacanthomas and squamous cell carcinomas after treatment with infliximab","volume":"50","author":"Esser","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2009.12.003_bib18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archderm.141.7.861","article-title":"No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years","volume":"141","author":"Lebwohl","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.annder.2009.12.003_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1365-2133.2006.07713.x","article-title":"Sezary syndrome in a patient receiving infliximab for ankylosing spondylilis","volume":"156","author":"Dauendorffer","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2009.12.003_bib20","first-page":"834","article-title":"Mycosis fungoides in a patient with ankylosing spondylitis during infliximab therapy","volume":"6","author":"Sanli","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.annder.2009.12.003_bib21","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jaad.2006.12.024","article-title":"Eruptive latent metastatic melanomas after initiation of antitumor necrosis factor therapies","volume":"56","author":"Fulchiero","year":"2007","journal-title":"J Am Acad Dermatol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809007601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963809007601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T10:55:24Z","timestamp":1758970524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963809007601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["S0151963809007601"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2009.12.003","relation":{},"ISSN":["0151-9638"],"issn-type":[{"type":"print","value":"0151-9638"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u00c9v\u00e9nements cutan\u00e9omuqueux au cours des traitements par anti-TNF alpha\u00a0: \u00e9tude observationnelle prospective de 41\u00a0cas","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2009.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}